Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | exonuclease III APE | 0.0018 | 0 | 0.5 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel 4 | 0.0095 | 0.5742 | 0.5742 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.1031 | 0.1031 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0 | 0.5 |
Brugia malayi | Transient-receptor-potential like protein | 0.0035 | 0.1269 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.374 | 0.374 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.4325 | 0.4325 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3093 | 0.3093 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.0153 | 1 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0153 | 1 | 1 |
Echinococcus granulosus | transient receptor potential ion channel A | 0.0092 | 0.5504 | 0.5504 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | transient receptor potential gamma protein | 0.0095 | 0.5742 | 0.5742 |
Echinococcus granulosus | transient receptor potential gamma protein | 0.0095 | 0.5742 | 0.5742 |
Schistosoma mansoni | hypothetical protein | 0.0153 | 1 | 1 |
Echinococcus multilocularis | TRP (transient receptor potential) channel | 0.0035 | 0.1269 | 0.1269 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0145 | 0.9445 | 0.9445 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0063 | 0.3331 | 0.3331 |
Schistosoma mansoni | transient receptor potential channel | 0.0095 | 0.5742 | 0.5742 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0018 | 0 | 0.5 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0018 | 0 | 0.5 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0063 | 0.3331 | 0.3331 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0018 | 0 | 0.5 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | transient receptor potential channel | 0.0063 | 0.3331 | 0.3331 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0063 | 0.3331 | 0.3331 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.5742 | 0.5742 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0063 | 0.3331 | 0.3331 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | transient receptor potential ion channel A | 0.0092 | 0.5504 | 0.5504 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1269 | 0.1269 |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0063 | 0.3331 | 0.3331 |
Echinococcus granulosus | TRP transient receptor potential channel | 0.0035 | 0.1269 | 0.1269 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 2 mM | Inhibition of mushroom tyrosinase after 30 mins | ChEMBL. | 20729091 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.